Alumier MD Post Procedure Kit with Hydrocortisone

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Alumier MD Post Procedure Kit with Hydrocortisone
Generic name: TITANIUM DIOXIDE, ZINC OXIDE, HYDROCORTISONE
Manufacturer: Alumier Labs
Product type: HUMAN OTC DRUG
SPL set ID: 2551d748-c3d6-cd18-e063-6294a90adab6
SPL ID: 2551d9c3-b0ce-c683-e063-6294a90ad978
Version: 1
Effective date: 2024-10-25
Source export date: 2026-09-28
Source partition: 3
Source file: https://download.open.fda.gov/drug/label/drug-label-0003-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/fd09911bd1bc81f7f2faeb048e63855fe224e494376ae919a0035190e315c050/drug-label-0003-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 05:18:02

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 10 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M020	openfda.application_number
brand name		Alumier MD Post Procedure Kit with Hydrocortisone	openfda.brand_name
generic name		TITANIUM DIOXIDE, ZINC OXIDE, HYDROCORTISONE	openfda.generic_name
manufacturer name		Alumier Labs	openfda.manufacturer_name
ndc	package	69473-020-01	openfda.package_ndc
ndc	product	69473-020	openfda.product_ndc
ndc11	package	69473002001	derived:openfda.package_ndc
rxcui		106258	openfda.rxcui
spl id		2551d9c3-b0ce-c683-e063-6294a90ad978	id
spl set id		2551d748-c3d6-cd18-e063-6294a90adab6	set_id

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only Do not use Clear Shield: on broken skin Intensive Recovery: for the treatment of diaper rash, except on the advice of a physician When using this product Clear Shield: avoid contact with eyes. If contact occurs, rinse thoroughly with water. Intensive Recovery: avoid contact with eyes, do not use in or around the eyes Stop use and ask a doctor Clear Shield: if rash occurs Intensive Recovery: if condition worsens or if symptoms persist for more than 7 days or clears up and occurs again within a few days. Do not begin use of any other hydrocortisone product unless directed by a physician. Keep out of reach of children If swallowed, call a Poison Control Centre or get medical help right away.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.